Embla Medical hf. (CPH:EMBLA)

Embla Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	91.77	86.16	72.65	76.63	85.2	102.36
Cash & Short-Term Investments	91.77	86.16	72.65	76.63	85.2	102.36
Cash Growth	18.63%	18.59%	-5.19%	-10.05%	-16.77%	74.65%
Accounts Receivable	125.98	121.92	127.84	112.37	102.77	98.35
Other Receivables	-	7.36	5.52	4.36	2.76	13.64
Receivables	125.98	129.28	133.37	116.74	105.52	112
Inventory	153.88	143.1	136.23	132.13	103.99	93.23
Prepaid Expenses	-	22.63	17.66	14.5	14.05	12.84
Other Current Assets	47.68	15.78	16.07	8.86	9.48	6.02
Total Current Assets	419.31	396.96	375.98	348.85	318.23	326.46
Property, Plant & Equipment	207.78	199.63	186.06	179.32	182.08	171.38
Long-Term Investments	23.67	21.22	23.44	17.08	13.65	13.35
Goodwill	789.25	776.31	690.86	680.4	644.15	612.19
Other Intangible Assets	97.32	96.65	65.84	62	58.84	59.5
Long-Term Deferred Tax Assets	48.67	46.37	41.89	37.32	27.04	27.51
Other Long-Term Assets	2.65	1.85	1.63	0.39	2.92	3.94
Total Assets	1,589	1,539	1,386	1,325	1,247	1,214
Accounts Payable	34.8	27.28	30.75	28.65	26.72	20.02
Accrued Expenses	46.96	76.73	78.86	63.35	62.49	60.68
Current Portion of Long-Term Debt	37.26	28.62	21.53	62.07	46.04	17.55
Current Portion of Leases	23.96	24.14	21.79	24.77	21.24	17.86
Current Income Taxes Payable	19.5	18.31	12.14	11.01	7.35	4.16
Current Unearned Revenue	-	2.72	2.84	3.32	3.37	3.1
Other Current Liabilities	78.6	31.5	28.28	43.84	19.24	23.94
Total Current Liabilities	241.07	209.28	196.2	237.01	186.46	147.31
Long-Term Debt	338.69	328.75	311.8	277.71	262.19	339.98
Long-Term Leases	128.65	118.28	112.61	116.38	118.67	108.01
Long-Term Unearned Revenue	8.64	8.59	7.28	6.04	6.25	6.74
Long-Term Deferred Tax Liabilities	36.76	37.48	28.78	29.6	29.03	26.05
Other Long-Term Liabilities	33.18	55.88	24.02	23.12	17.72	9.05
Total Liabilities	786.98	758.27	680.68	689.85	620.32	637.14
Common Stock	4.83	4.83	4.78	4.78	4.8	4.79
Additional Paid-In Capital	87.36	88.64	61.48	61.43	70.78	70.08
Retained Earnings	773.51	760.38	700.93	641.23	593.2	530.42
Comprehensive Income & Other	-67.62	-76.66	-65.31	-71.74	-47.18	-32.78
Total Common Equity	798.08	777.19	701.88	635.7	621.59	572.51
Minority Interest	3.6	3.51	3.12	-0.19	5.01	4.68
Shareholders' Equity	801.68	780.7	705.01	635.51	626.6	577.19
Total Liabilities & Equity	1,589	1,539	1,386	1,325	1,247	1,214
Total Debt	528.55	499.79	467.73	480.92	448.15	483.39
Net Cash (Debt)	-436.78	-413.63	-395.08	-404.29	-362.95	-381.03
Net Cash Per Share	-1.02	-0.97	-0.94	-0.97	-0.86	-0.90
Filing Date Shares Outstanding	426.64	426.93	420.3	420.29	422.26	422.1
Total Common Shares Outstanding	426.64	426.93	420.3	420.29	422.26	422.1
Working Capital	178.24	187.67	179.78	111.84	131.78	179.15
Book Value Per Share	1.87	1.82	1.67	1.51	1.47	1.36
Tangible Book Value	-88.5	-95.77	-54.81	-106.7	-81.4	-99.18
Tangible Book Value Per Share	-0.21	-0.22	-0.13	-0.25	-0.19	-0.23
Buildings	-	-	-	2.26	1.61	2.25
Machinery	112.94	109	101.68	129.71	135.77	130.55
Leasehold Improvements	52.66	51.27	42.81	-	-	-

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.